This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2018 Dec 20;379(25):2463-2464.

doi: 10.1056/NEJMe1813684.

A Glimmer of Hope for Pancreatic Cancer

Hedy L Kindler¹

Affiliations

PMID: 30575492
DOI: 10.1056/NEJMe1813684

Editorial

A Glimmer of Hope for Pancreatic Cancer

Hedy L Kindler. N Engl J Med. 2018.

. 2018 Dec 20;379(25):2463-2464.

doi: 10.1056/NEJMe1813684.

Author

Hedy L Kindler¹

Affiliation

¹ From the Section of Hematology-Oncology, University of Chicago Medicine, Chicago.

PMID: 30575492
DOI: 10.1056/NEJMe1813684

No abstract available

PubMed Disclaimer

Comment on

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul JL, Choné L, Francois E, Artru P, Biagi JJ, Lecomte T, Assenat E, Faroux R, Ychou M, Volet J, Sauvanet A, Breysacher G, Di Fiore F, Cripps C, Kavan P, Texereau P, Bouhier-Leporrier K, Khemissa-Akouz F, Legoux JL, Juzyna B, Gourgou S, O'Callaghan CJ, Jouffroy-Zeller C, Rat P, Malka D, Castan F, Bachet JB; Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group. Conroy T, et al. N Engl J Med. 2018 Dec 20;379(25):2395-2406. doi: 10.1056/NEJMoa1809775. N Engl J Med. 2018. PMID: 30575490 Clinical Trial.

Similar articles

[S‑1 versus gemcitabine for adjuvant therapy in pancreatic cancer].
Strobel O, Büchler MW. Strobel O, et al. Chirurg. 2016 Oct;87(10):892. doi: 10.1007/s00104-016-0282-2. Chirurg. 2016. PMID: 27586535 German. No abstract available.
Survival for patients with pancreatic cancer after addition of gemcitabine to fluorouracil chemoradiation.
Vikram B. Vikram B. JAMA. 2008 Jun 25;299(24):2852; author reply 2852-3. doi: 10.1001/jama.299.24.2852-b. JAMA. 2008. PMID: 18577724 No abstract available.
Survival for patients with pancreatic cancer after addition of gemcitabine to Fluorouracil chemoradiation.
Fujita T. Fujita T. JAMA. 2008 Jun 25;299(24):2852; author reply 2852-3. doi: 10.1001/jama.299.24.2852-a. JAMA. 2008. PMID: 18577725 No abstract available.
[Results of gemcitabine hydrochloride in the treatment for pancreatic cancer].
Tsukagoshi S. Tsukagoshi S. Gan To Kagaku Ryoho. 2001 Oct;28(10):1461-7. Gan To Kagaku Ryoho. 2001. PMID: 11681259 Review. Japanese.
[Conservative therapy for pancreatic cancer].
Ito T, Arita Y, Kawabe K, Hisano T, Nawata H. Ito T, et al. Nihon Naika Gakkai Zasshi. 2004 Jan 10;93(1):64-9. doi: 10.2169/naika.93.64. Nihon Naika Gakkai Zasshi. 2004. PMID: 14968576 Review. Japanese. No abstract available.

See all similar articles

Cited by

hsa_circ_0007919 induces LIG1 transcription by binding to FOXA1/TET1 to enhance the DNA damage response and promote gemcitabine resistance in pancreatic ductal adenocarcinoma.
Xu L, Ma X, Zhang X, Zhang C, Zhang Y, Gong S, Wu N, Zhang P, Feng X, Guo J, Zhao M, Ren Z, Zhang P. Xu L, et al. Mol Cancer. 2023 Dec 4;22(1):195. doi: 10.1186/s12943-023-01887-8. Mol Cancer. 2023. PMID: 38044421 Free PMC article.
Endoscopic ultrasound-guided biliary drainage for distal malignant obstruction: a systematic review and meta-analysis of randomized trials.
Miller CS, Barkun AN, Martel M, Chen YI. Miller CS, et al. Endosc Int Open. 2019 Nov;7(11):E1563-E1573. doi: 10.1055/a-0998-8129. Epub 2019 Nov 11. Endosc Int Open. 2019. PMID: 31723579 Free PMC article.
Cucurbitacin I inhibits the proliferation of pancreatic cancer through the JAK2/STAT3 signalling pathway in vivo and in vitro.
Xu D, Shen H, Tian M, Chen W, Zhang X. Xu D, et al. J Cancer. 2022 Mar 28;13(7):2050-2060. doi: 10.7150/jca.65875. eCollection 2022. J Cancer. 2022. PMID: 35517401 Free PMC article.
Tumor-derived exosomes in the regulation of macrophage polarization.
Baig MS, Roy A, Rajpoot S, Liu D, Savai R, Banerjee S, Kawada M, Faisal SM, Saluja R, Saqib U, Ohishi T, Wary KK. Baig MS, et al. Inflamm Res. 2020 May;69(5):435-451. doi: 10.1007/s00011-020-01318-0. Epub 2020 Mar 11. Inflamm Res. 2020. PMID: 32162012 Review.
Quercetin facilitates cell death and chemosensitivity through RAGE/PI3K/AKT/mTOR axis in human pancreatic cancer cells.
Lan CY, Chen SY, Kuo CW, Lu CC, Yen GC. Lan CY, et al. J Food Drug Anal. 2019 Oct;27(4):887-896. doi: 10.1016/j.jfda.2019.07.001. Epub 2019 Aug 21. J Food Drug Anal. 2019. PMID: 31590760 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information